2020 American Transplant Congress
A NASHional Crisis: Liver Transplantation Outcomes in Female Hispanics
1Pathology and Lab Medicine, UCLA, Los Angeles, CA, 2Surgery, UCLA, Los Angeles, CA
*Purpose: Obesity and metabolic syndrome have recently become an epidemic with Hispanics bearing a disproportionate burden. Non-alcoholic steatohepatitis (NASH) is a severe immune-mediated stage of…2020 American Transplant Congress
The Long Term Impact of Metabolic Syndrome on Post-Donation in Living Kidney Donors
Division of Nephrology, Taichung Veterans General Hospital, Taichung, Taiwan
*Purpose: The long waiting list for kidney transplant (KTx) in Taiwan, the willingness of transplant centers increase to accept complex donors, eg. metabolic syndrome (MS).…2020 American Transplant Congress
The Impact of Preoperative Glucose Intolerance and Hypertension on the Living Kidney Donors
*Purpose: Recently the mortality of living kidney donors was demonstrated to be significantly worse than that of healthy general population. However, the impact of preoperative…2020 American Transplant Congress
Marginal Livers Have Excellent Outcomes in Pediatric Patients with Metabolic Liver Disease
*Purpose: Pediatric patients with metabolic diseases are listed so that livers are preferentially allocated to them, having the option of receiving a very high quality…2020 American Transplant Congress
Perioperative Management and Post-Liver Transplantation Outcomes in Methylmalonic Acidemia, Propionic Acidemia and Urea Cycle Disorders: 20 Years’ Experience
1Surgery, Stanford University, Palo Alto, CA, 2Pediatrics, Stanford University, Palo Alto, CA
*Purpose: To examine long-term outcomes after liver transplantation for organic acidemias and urea cycle defects at our center which utilizes standardized pre-, peri- and post-operative…2019 American Transplant Congress
Pediatric Liver Transplantation for Metabolic Disorders without Intrinsic Liver Disease: A 25 Year Experience
Stanford University Medical Center, Palo Alto, CA
*Purpose: Liver transplantation (LT) for acute and chronic end-stage-liver-disease is a well-accepted therapy in pediatrics. However, for children with metabolic disorders (MD) without intrinsic liver…2019 American Transplant Congress
Long-Term Outcomes in Patients with Obesity and Renal Disease after Sleeve Gastrectomy
Department of Surgery, University of Cincinnati, Cincinnati, OH
*Purpose: Morbid obesity is a barrier to kidney transplantation in patients with end-stage renal disease (ESRD) and is associated with progression of chronic kidney disease…2019 American Transplant Congress
Comparison of Two Glucagon-Like-Peptide-1 Analogs (GLP -1) Dulaglutide vs Liraglutide for the Management of Diabetes in Solid Organ Transplant (SOT)
Ohio State University, Columbus, OH
*Purpose: Poorly controlled Type-2 diabetes is an important contributor to graft dysfunction, and cardiovascular morbidity in the SOT. GLP-1-analog has been widely used in the…2019 American Transplant Congress
TDCA/Valine Reverse Obesity and Ameliorate Alloimmune Responses through a Decreased Hypothalamic Expression of MCH
1Brigham and Women's Hospital, Boston, AL, 2Beth Israel Deaconess Medical Center, Boston, AL
*Purpose: Obesity is associated with low grade inflammation and bariatric surgery is the only effective treatment in reducing excess weight both pre- and post-transplant.*Methods: Here,…2019 American Transplant Congress
Extremes of Body Mass Index is Associated with Inferior Renal Allograft Outcomes in Type 2 Diabetic Deceased Donor Renal Transplant Recipients
SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: We evaluated the trends and renal allograft outcomes in type 2 diabetic renal transplant recipients stratified by body mass index (BMI).*Methods: All adult type…
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- 6
- …
- 8
- Next Page »